Sale on Ophthalmic Equipment - Starting from 16 November!
Zimmer Biomet has filed a 510(k) for an autonomous version of its Monogram orthopaedic robot and hopes for FDA clearance next year, with a 2027 launch.
The Zimmer Monogram robot is now with US regulators. Zimmer Biomet has filed a 510(k) submission for an autonomous version of its Monogram orthopaedic robot, a company spokesperson confirmed. The company hopes for Food and Drug Administration clearance next year.
Chief executive Ivan Tornos told an investor event this week that Zimmer made the filing on Monday. He said he expects Monogram to be a platform that changes the field, pointing to its accuracy, safety, efficiency and ease of use. Zimmer's 510(k) is a 90 day submission. Tornos expects some back and forth with the FDA, because the technology is new to the world. The company now expects a launch in 2027, ahead of an earlier plan for 2028.
Zimmer bought Monogram Technologies in 2025 for $177 million. Monogram then offered a semi autonomous robot for total knee replacement operations. It was developing a fully autonomous successor, designed to be hands free and activated by foot pedals. The deal gave Zimmer a route into autonomous orthopaedic surgery beyond Rosa.
The Zimmer Monogram robot differs from Rosa, Zimmer's existing orthopaedic robot, because it can work with CT imaging. Tornos said the clinical trial recorded no safety events. He added that the robot sped up preparing the bone and marking landmarks before surgery.
Two orthopaedic surgeons discussed the robot at a Stifel conference on Sunday. Stifel analyst Rick Wise wrote that they saw potential for meaningful time savings, fewer instrument trays and better accuracy. They added that automated bone cutting could ease the physical strain of surgery on surgeons. These are early impressions from surgeons at an investor conference, not regulatory findings.
The Zimmer Monogram robot would add an autonomous option to a crowded orthopaedic robotics market. The system is under FDA review and not yet cleared. Medigear.uk helps clinical buyers compare verified suppliers. UK buyers should note the source does not give UK availability. Performance claims here are Zimmer's and the surgeons' own, and the FDA has not yet ruled.
Source: MedTech Dive
Tell us the model and destination — our sourcing team will respond within one business day.

The Abbott Encantor trial has begun. Abbott said on Thursday that it has started the VOYAGER CE clin…

Johnson & Johnson (J&J) said on Thursday that a Houston hospital will be the first to instal…

The Exo Gates Foundation grant is worth $11.6 million. Exo, a handheld ultrasound company, announced…
Approvals, trials, recalls and market moves — the essentials for procurement and clinical teams.